Injective (INJ) is currently trading at $3.06, reflecting a slight increase of 0.28% over the last 24 hours. The price has fluctuated within a daily range of $2.99 to $3.08, indicating relatively stable trading activity with a narrow daily range of 0.09%.

Trading volume stands at approximately 47.76 million, translating to a volume-to-market cap ratio of 15.60%, suggesting healthy liquidity and interest from traders. The hourly moving averages show mixed signals; while the 8 SMA is slightly negative at -0.07%, longer-term averages like the 55 SMA show a positive trend of +0.90%, indicating potential bullish sentiment.

The 1-hour RSI is at 64, suggesting that INJ is nearing overbought territory, which could imply a short-term price correction may be imminent. In contrast, the 7-day RSI of 51 indicates a neutral trend, which aligns with a recent 7-day price decline of approximately 5.59%, highlighting some bearish pressure over the week.

Over the past 14 days, INJ has shown a slight positive price change of 4.16%, while the 30-day performance remains negative at -9.50%, indicating a longer-term downtrend. The all-time high of $52.62 reached in March 2024 is significantly above the current price, reflecting potential for future growth if market conditions improve.

Given the mixed signals from both short-term and long-term indicators, coupled with the current price being well below its all-time high, a Hold rating is recommended. This strategy allows investors to monitor for potential upward momentum while avoiding the risk of a short-term correction based on the RSI levels.